Dow Up0.08% Nasdaq Down0.30%

Skystar Bio Pharmaceutical Company (SKBI)

-NCM
4.45 Up 0.02(0.45%) 3:57PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 14,240   6,833   9,625   15,992  
Cost of Revenue7,881  4,009  4,906  7,779  
Gross Profit 6,359   2,823   4,720   8,214  
Operating Expenses
Research Development799  4  538  324  
Selling General and Administrative2,192  1,647  1,523  3,152  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 3,368   1,172   2,659   4,738  
Income from Continuing Operations
Total Other Income/Expenses Net262  309  702  (447)
Earnings Before Interest And Taxes3,630  1,481  3,361  4,291  
Interest Expense137  76  427  (225)
Income Before Tax3,493  1,405  2,934  4,516  
Income Tax Expense682  430  601  782  
Minority Interest -   -   -   -  
Net Income From Continuing Ops2,811  975  2,332  3,734  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 2,811   975   2,332   3,734  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 2,811   975   2,332   3,734  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.